Literature DB >> 23060061

Human correlates of provocative questions in pancreatic pathology.

Oliver G McDonald1, Anirban Maitra, Ralph H Hruban.   

Abstract

Studies of cell lines and of animal models of pancreatic cancer have raised a number of provocative questions about the nature and origins of human pancreatic cancer and have provided several leads into exciting new approaches for the treatment of this deadly cancer. In addition, clinicians with little or no contact with human pathology have challenged the way that pancreatic pathology is practiced, suggesting that "genetic signals" may be more accurate than today's multimodal approach to diagnoses. In this review, we consider 8 provocative issues in pancreas pathology, with an emphasis on "the evidence derived from man."

Entities:  

Mesh:

Year:  2012        PMID: 23060061      PMCID: PMC3487591          DOI: 10.1097/PAP.0b013e318273f998

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  125 in total

Review 1.  The ins and outs of the epithelial to mesenchymal transition in health and disease.

Authors:  M Angela Nieto
Journal:  Annu Rev Cell Dev Biol       Date:  2011-07-08       Impact factor: 13.827

2.  Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Suresh T Chari; Dhiraj Yadav; Thomas C Smyrk; Eugene P DiMagno; Laurence J Miller; Massimo Raimondo; Jonathan E Clain; Ian A Norton; Randall K Pearson; Bret T Petersen; Maurits J Wiersema; Michael B Farnell; Michael G Sarr
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

3.  Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.

Authors:  R E Wilentz; G H Su; J L Dai; A B Sparks; P Argani; T A Sohn; C J Yeo; S E Kern; R H Hruban
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

4.  Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.

Authors:  Jian Wu; Hanno Matthaei; Anirban Maitra; Marco Dal Molin; Laura D Wood; James R Eshleman; Michael Goggins; Marcia I Canto; Richard D Schulick; Barish H Edil; Christopher L Wolfgang; Alison P Klein; Luis A Diaz; Peter J Allen; C Max Schmidt; Kenneth W Kinzler; Nickolas Papadopoulos; Ralph H Hruban; Bert Vogelstein
Journal:  Sci Transl Med       Date:  2011-07-20       Impact factor: 17.956

Review 5.  Dangerous liaisons: pancreatic stellate cells and pancreatic cancer cells.

Authors:  Minoti V Apte; Jeremy S Wilson
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

6.  Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer.

Authors:  E Van Cutsem; H van de Velde; P Karasek; H Oettle; W L Vervenne; A Szawlowski; P Schoffski; S Post; C Verslype; H Neumann; H Safran; Y Humblet; J Perez Ruixo; Y Ma; D Von Hoff
Journal:  J Clin Oncol       Date:  2004-04-15       Impact factor: 44.544

7.  A paracrine requirement for hedgehog signalling in cancer.

Authors:  Robert L Yauch; Stephen E Gould; Suzie J Scales; Tracy Tang; Hua Tian; Christina P Ahn; Derek Marshall; Ling Fu; Thomas Januario; Dara Kallop; Michelle Nannini-Pepe; Karen Kotkow; James C Marsters; Lee L Rubin; Frederic J de Sauvage
Journal:  Nature       Date:  2008-08-27       Impact factor: 49.962

8.  Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.

Authors:  Arnout G Schepers; Hugo J Snippert; Daniel E Stange; Maaike van den Born; Johan H van Es; Marc van de Wetering; Hans Clevers
Journal:  Science       Date:  2012-08-01       Impact factor: 47.728

9.  The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma.

Authors:  Pedro A Pérez-Mancera; Alistair G Rust; Louise van der Weyden; Glen Kristiansen; Allen Li; Aaron L Sarver; Kevin A T Silverstein; Robert Grützmann; Daniela Aust; Petra Rümmele; Thomas Knösel; Colin Herd; Derek L Stemple; Ross Kettleborough; Jacqueline A Brosnan; Ang Li; Richard Morgan; Spencer Knight; Jun Yu; Shane Stegeman; Lara S Collier; Jelle J ten Hoeve; Jeroen de Ridder; Alison P Klein; Michael Goggins; Ralph H Hruban; David K Chang; Andrew V Biankin; Sean M Grimmond; Lodewyk F A Wessels; Stephen A Wood; Christine A Iacobuzio-Donahue; Christian Pilarsky; David A Largaespada; David J Adams; David A Tuveson
Journal:  Nature       Date:  2012-04-29       Impact factor: 49.962

10.  Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells.

Authors:  G Greenburg; E D Hay
Journal:  J Cell Biol       Date:  1982-10       Impact factor: 10.539

View more
  14 in total

1.  Absence of pancreatic intraepithelial neoplasia predicts poor survival after resection of pancreatic cancer.

Authors:  Benjamin G Hassid; Aimee L Lucas; Marcela Salomao; Chunhua Weng; Feng Liu; Lauren G Khanna; Sheila Kumar; Caroline Hwang; John A Chabot; Harold Frucht
Journal:  Pancreas       Date:  2014-10       Impact factor: 3.327

2.  EMT in cancer.

Authors:  Thomas Brabletz; Raghu Kalluri; M Angela Nieto; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2018-01-12       Impact factor: 60.716

3.  Harnessing immune responses in the tumor microenvironment: all signals needed.

Authors:  Dung T Le; Elizabeth M Jaffee
Journal:  Clin Cancer Res       Date:  2013-10-04       Impact factor: 12.531

4.  Snail cooperates with KrasG12D to promote pancreatic fibrosis.

Authors:  Mario A Shields; Kazumi Ebine; Vaibhav Sahai; Krishan Kumar; Kulsumjehan Siddiqui; Rosa F Hwang; Paul J Grippo; Hidayatullah G Munshi
Journal:  Mol Cancer Res       Date:  2013-06-12       Impact factor: 5.852

Review 5.  The biology of pancreatic cancer morphology.

Authors:  Oliver G McDonald
Journal:  Pathology       Date:  2021-12-03       Impact factor: 5.306

6.  A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells.

Authors:  Irene Ischenko; Oleksi Petrenko; Michael J Hayman
Journal:  Oncotarget       Date:  2015-06-30

7.  The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells.

Authors:  Daniel Barnett; Ying Liu; Katie Partyka; Ying Huang; Huiyuan Tang; Galen Hostetter; Randall E Brand; Aatur D Singhi; Richard R Drake; Brian B Haab
Journal:  Sci Rep       Date:  2017-06-22       Impact factor: 4.379

8.  Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.

Authors:  Xiaofeng Zheng; Julienne L Carstens; Jiha Kim; Matthew Scheible; Judith Kaye; Hikaru Sugimoto; Chia-Chin Wu; Valerie S LeBleu; Raghu Kalluri
Journal:  Nature       Date:  2015-11-11       Impact factor: 49.962

9.  Increased SPARC expression is associated with neoadjuvant therapy in resectable pancreatic ductal adenocarcinoma.

Authors:  Christopher Hartley; Daniel Rowan; Xiuxu Chen; Luisa Gomez-Arellano; Anna Marie West; Kiyoko Oshima; Alexander Craig Mackinnon
Journal:  Pract Lab Med       Date:  2020-05-29

10.  Active K-RAS induces the coherent rotation of epithelial cells: A model for collective cell invasion in vitro.

Authors:  Eishu Hirata; Takehiko Ichikawa; Shin-Ichi Horike; Etsuko Kiyokawa
Journal:  Cancer Sci       Date:  2018-11-05       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.